CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that Russia’s Federal Medical-Biological Agency (FMBA) has awarded contracts for the purchase of 19 INTERCEPT Blood System illumination devices for blood centers throughout the country. Cerus will supply the INTERCEPT Illuminators through a Russian distributor.
